Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
NCT01411852 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 192
Last updated 2015-01-13
Summary
Primary Aim: To determine the feasibility and safety of hypotensive resuscitation for the early treatment of patients with traumatic shock compared to standard fluid resuscitation.
Primary Hypotheses: The null hypothesis regarding feasibility is that hypotensive resuscitation will result in the same volume of early crystalloid (normal saline) fluid administration compared to standard crystalloid resuscitation. The null hypothesis regarding safety is that hypotensive resuscitation will result in the same percent of patients surviving to 24 hours after 911 call received at dispatch compared to standard fluid resuscitation. Early resuscitation is defined as all fluid given until 2 hours after arrival in the Emergency Department or until hemorrhage control is achieved in the hospital, whichever occurs earlier.
Conditions
- Blunt Trauma
- Penetrating Wound
- Hemorrhagic Shock
Interventions
- DRUG
-
0.9% Sodium Chloride 250 mL bolus
Emergency Medicine Systems (EMS) agencies and in-hospital providers will be given the option to utilize either systolic blood pressure (SBP) or radial pulse as the endpoint for fluid resuscitation to patients randomized to the experimental group. Patients will receive a 250 ml bolus of normal saline (NS) only if the SBP is less than 70 mmHg or the radial pulse is not palpable. If the SBP is greater than or equal to 70 mmHg or the radial pulse is palpable, NS will be given to keep the vein open. The presence or absence of a radial pulse or the SBP will be documented before and after each bolus. The study will continue repeating the randomization procedure using only 250 ml bags of NS until 2 hours after arrival to the hospital or until hemorrhage control is achieved whichever occurs first.
- DRUG
-
0.9% Sodium Chloride 2000 mL bolus
Emergency Medicine Systems (EMS) personnel and in-hospital providers will utilize the systolic blood pressure SBP as the endpoint for delivering fluid resuscitation to patients randomized to the control group. If the SBP is equal to or less than 90 mmHg, the EMS personnel will start infusing a 1000 ml bolus of normal saline (NS) and will continue using only 1000 ml bags of NS as needed. If the total fluid resuscitation exceeds 2 liters, fluid will be stopped when the SBP exceeds 110 mmHg and restarted as necessary to maintain a goal SBP of 110 mmHg. The fluid will be given as rapidly as possible. This fluid resuscitation protocol will continue until either 2 hours after hospital arrival or until control of hemorrhage is achieved whichever occurs first.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV - lead OTHER
Principal Investigators
-
Myron L Weisfeldt, MD · Resuscitation Outcomes Consortium
-
David Hoyt, MD · Resuscitation Outcomes Consortium
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
The Impact of the Fluid Resuscitation on the Venous Volume and Flow Characteristics in Hypovolemic Shock
NCT02474056 ·Status: WITHDRAWN
-
Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department
NCT05369559 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in Shock
NCT02666404 ·Status: TERMINATED ·Phase: NA
-
Effect of Giving Reduced Fluid in Children After Trauma
NCT04201704 ·Status: RECRUITING ·Phase: NA
-
Study of Virtual Simulated Resuscitation in Junior Clinicians
NCT05201950 ·Status: COMPLETED ·Phase: NA
-
Optimal Fluid Resuscitation for Trauma Patients
NCT00527098 ·Status: COMPLETED
-
Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis
NCT05453565 ·Status: NOT_YET_RECRUITING
-
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
NCT01393782 ·Status: COMPLETED ·Phase: PHASE1
-
Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control
NCT02542241 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women With Fetal Heart Rate Tracing Category II: A Randomized Controlled Trial
NCT07260240 ·Status: RECRUITING ·Phase: NA
-
Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock
NCT06481839 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Strong Albumin Solutions in Patients With Septic Shock
NCT05208242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimal VAsopressor titraTION Pilot Randomized Controlled Trial
NCT01800877 ·Status: COMPLETED ·Phase: NA
-
Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients
NCT06370975 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
NCT01309724 ·Status: COMPLETED ·Phase: NA
-
Fluids in Septic Shock (FISSH)
NCT03677102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation
NCT04282252 ·Status: COMPLETED ·Phase: PHASE4
-
Variation in Fluids Administered in Shock
NCT03190408 ·Status: COMPLETED
-
Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)
NCT01128413 ·Status: TERMINATED ·Phase: NA
-
Hypertonic Modulation of Inflammation Following Injury
NCT00750997 ·Status: TERMINATED
-
Proving Hemodilution in a Human Model for Class I Hemorrhage
NCT02318355 ·Status: COMPLETED ·Phase: NA
-
Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance
NCT06111261 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension
NCT01271114 ·Status: TERMINATED ·Phase: PHASE3
-
VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
NCT04089098 ·Status: COMPLETED
-
Whether a Minimal Volume Could Predict Fluid Responsiveness Using Thermodilution by PAC in Septic Shock Patients
NCT04515511 ·Status: UNKNOWN ·Phase: NA